Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/9/24 13:18 | 9/6/24 | NUTX | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Timur | IL | O | CTO | 2 | P.a | 40 | 0.2900 | 0 | 138 | 232 | 197 | D | ||||||||||||||
10/8/24 10:42 | 9/6/24 | NUTX | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | DO | CEO | 4 | P | 80 | 0.2900 | 0 | 276 | 20 | 1,684 | D | ||||||||||||||
9/10/24 17:22 | 9/6/24 | CDIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Philibert Robert | IL | DO | Chief Me | 1 | P | 10 | 0.2865 | 0 | 34 | 2 | 1,684 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |